公开(公告)号：US08338420B1

公开(公告)日：2012-12-25

申请号：US12647880

申请日：2009-12-28

申请人： Jun Kotera ,  Takashi Sasaki ,  Takeo Kitazawa ,  Taketoshi Ishii ,  Hiroshi Morimoto ,  Harutami Yamada

发明人： Jun Kotera ,  Takashi Sasaki ,  Takeo Kitazawa ,  Taketoshi Ishii ,  Hiroshi Morimoto ,  Harutami Yamada

IPC分类号： A61K31/50 ,  A61K31/40 ,  C07D471/22

CPC分类号： A61K31/198 ,  A61K31/137 ,  A61K31/165 ,  A61K31/352 ,  A61K31/48 ,  A61K31/4985 ,  A61K31/517 ,  A61K31/55 ,  C07D403/14 ,  A61K2300/00

摘要： The present invention relates to a therapeutic or prophylactic method for treating Parkinson's disease by administering an effective amount of a compound having a phosphodiesterase 10 inhibitory activity; and also relates to a pharmaceutical composition for treatment or prophylaxis of Parkinson's disease comprising as an active ingredient a compound having a phosphodiesterase 10 inhibitory activity. Moreover, the present invention relates to a method for enhancing dopamine signal in the brain, which comprises administering an effective amount of a compound having a phosphodiesterase 10 inhibitory activity; and also relates to pharmaceutical composition for enhancing dopamine signal in brain comprising as an active ingredient a compound having a phosphodiesterase 10 inhibitory activity.

摘要翻译： 本发明涉及通过施用有效量的具有磷酸二酯酶10抑制活性的化合物治疗帕金森病的治疗或预防方法; 并且还涉及用于治疗或预防帕金森病的药物组合物，其包含具有磷酸二酯酶10抑制活性的化合物作为活性成分。 此外，本发明涉及一种增强脑中多巴胺信号的方法，其包括给予有效量的具有磷酸二酯酶10抑制活性的化合物; 并且还涉及用于增强脑中多巴胺信号的药物组合物，其包含具有磷酸二酯酶10抑制活性的化合物作为活性成分。

公开(公告)号：US07332317B2

公开(公告)日：2008-02-19

申请号：US10168402

申请日：2000-12-22

申请人： Kenji Omori ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

发明人： Kenji Omori ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

IPC分类号： C12N9/16 ,  C07H21/04

CPC分类号： C12N9/16 ,  C12Q2521/119

摘要： The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39 in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

摘要翻译： 本发明提供一种新的磷酸二酯酶及其基因，特别是11型磷酸二酯酶（PDE11）及其基因，更具体地，提供选自（A）具有SEQ.ID所示的氨基酸测序的蛋白质的磷酸二酯酶。 SEQ ID NO：2，SEQ ID NO：4，SEQ ID NO：6或SEQ ID NO：39，和（B）具有SEQ ID NO：2，SEQ ID NO：2所示氨基酸序列的蛋白质 其中一个或几个氨基酸被缺失，取代或加入并且具有水解环状核苷酸的活性及其基因的SEQ ID NO：4，SEQ ID NO：6或SEQ ID NO：39 ，以及通过使用它们来表征，鉴定和选择磷酸二酯酶抑制剂的方法。

公开(公告)号：US08012731B2

公开(公告)日：2011-09-06

申请号：US11960999

申请日：2007-12-20

申请人： Kenji Omori ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

发明人： Kenji Omori ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

IPC分类号： C07H21/00 ,  C12N15/00 ,  C12Q1/68 ,  C12N1/21 ,  C12N5/10 ,  C12N9/16 ,  C12P21/00

CPC分类号： C12N9/16 ,  C12Q2521/119

摘要： The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39 in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

摘要翻译： 本发明提供一种新的磷酸二酯酶及其基因，特别是11型磷酸二酯酶（PDE11）及其基因，更具体地，提供选自（A）具有SEQ.ID所示的氨基酸测序的蛋白质的磷酸二酯酶。 SEQ ID NO：2，SEQ ID NO：4，SEQ ID NO：6或SEQ ID NO：39，和（B）具有SEQ ID NO：2，SEQ ID NO：2所示氨基酸序列的蛋白质 其中一个或几个氨基酸被缺失，取代或加入并且具有水解环状核苷酸的活性及其基因的SEQ ID NO：4，SEQ ID NO：6或SEQ ID NO：39 ，以及通过使用它们来表征，鉴定和选择磷酸二酯酶抑制剂的方法。

公开(公告)号：US20090325207A1

公开(公告)日：2009-12-31

申请号：US11960999

申请日：2007-12-20

申请人： Kenji OMORI ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

发明人： Kenji OMORI ,  Keizo Yuasa ,  Jun Kotera ,  Kotomi Oda ,  Hideo Michibata

IPC分类号： C12Q1/42 ,  C12N9/16 ,  C07H21/04 ,  C12N15/63 ,  C12N5/10

CPC分类号： C12N9/16 ,  C12Q2521/119

摘要： The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

摘要翻译： 本发明提供一种新的磷酸二酯酶及其基因，特别是11型磷酸二酯酶（PDE11）及其基因，更具体地，提供选自（A）具有SEQ.ID所示的氨基酸测序的蛋白质的磷酸二酯酶。 SEQ ID NO：2，SEQ ID NO：4，SEQ ID NO：6或SEQ ID NO：39，和（B）具有SEQ ID NO：2，SEQ ID NO：2所示氨基酸序列的蛋白质 其中一个或几个氨基酸被缺失，取代或加入并具有水解环状核苷酸的活性及其基因.ID.NO:4，SEQ.ID.NO:6或SEQ.ID.NO： 以及通过使用它们来表征，鉴定和选择磷酸二酯酶抑制剂的方法。